查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1265599

多模态成像的全球市场

Multimodal Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

多模态成像的全球市场在2030年前将达到35亿美元

在COVID-19后改变的商务环境中，2022年30亿美元的多模态成像的全球市场，在2022年～2030年预计将以年复合成长率完成1.9％的速度成长，在2030年前将达到35亿美元的规模。本报告所分析之市场区隔之一的PET/CT系统将以年复合成长率3％增长，到分析期间结束时将达到13亿美元。考虑疫情后的復苏，SPECT/CT系统领域今后8年的年复合成长率将修正为0.7％。

美国市场估算为8亿1,850万美元，中国则将以年复合成长率5.3％增长

美国的多模态成像市场在2022年估算为8亿1,850万美元。作为世界第2大经济大国的中国，在2022年～2030年年复合成长率预计将为5.3％，在2030年前将达到7亿6,470万美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年～2030年预计将各以-0.4％和0.9％的速度成长。在欧洲市场中，德国以年复合成长率约0.4％成长。

调查对像企业范例

  • Canon Medical Systems Corporation
  • Carl Zeiss AG
  • GE Healthcare
  • Heidelberg Engineering
  • Infraredx, Inc.
  • Koninklijke Philips N.V.
  • Mediso Medical Imaging Kft
  • MILabs B.V.
  • Neusoft Medical Systems Co., Ltd.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Siemens Healthineers
  • Spectrum Dynamics Medical
  • Topcon Corporation
  • United Imaging Healthcare Co., Ltd.

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他中东
  • 非洲

第4章 竞争

简介目录
Product Code: MCP22337

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Multimodal Imaging Market to Reach $3.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Multimodal Imaging estimated at US$3 Billion in the year 2022, is projected to reach a revised size of US$3.5 Billion by 2030, growing at aCAGR of 1.9% over the period 2022-2030. PET / CT Systems, one of the segments analyzed in the report, is projected to record 3% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the SPECT / CT Systems segment is readjusted to a revised 0.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $818.5 Million, While China is Forecast to Grow at 5.3% CAGR

The Multimodal Imaging market in the U.S. is estimated at US$818.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$764.7 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -0.4% and 0.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 0.4% CAGR.

Select Competitors (Total 42 Featured) -

  • Canon Medical Systems Corporation
  • Carl Zeiss AG
  • GE Healthcare
  • Heidelberg Engineering
  • Infraredx, Inc.
  • Koninklijke Philips N.V.
  • Mediso Medical Imaging Kft
  • MILabs B.V.
  • Neusoft Medical Systems Co., Ltd.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Siemens Healthineers
  • Spectrum Dynamics Medical
  • Topcon Corporation
  • United Imaging Healthcare Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Multimodal Imaging - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Multimodal Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Brain & Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 31: World Multimodal Imaging Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for PET / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for SPECT / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for SPECT / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for SPECT / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 39: World Historic Review for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: World 16-Year Perspective for PET / MR Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for OCT / Fundus Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 42: World Historic Review for OCT / Fundus Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: World 16-Year Perspective for OCT / Fundus Imaging Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: China 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Multimodal Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: France 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Multimodal Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: Australia 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • INDIA
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: India 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: India 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: India 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: South Korea 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Multimodal Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: Latin America 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: Argentina 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: Brazil 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Mexico 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Rest of Latin America 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Multimodal Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 262: Middle East 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 271: Iran 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 280: Israel 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 289: Saudi Arabia 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 298: UAE 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 307: Rest of Middle East 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • AFRICA
    • Multimodal Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2014, 2023 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 316: Africa 16-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION